Biotech3 months ago
Novonesis Increases Semiannual Billing by 7% and Increases Expectations for 2024
In the first half of 2024, Novonesis achieved broad-based sales growth driven by Food&Health Biosolutions (6% growth to €876 million) and Planetary Health Biosolutions (8% growth...